Mardia Samyoung Capillary Tubes Company Limited has completed multiple warrant conversions, resulting in the allotment of 1,17,15,000 equity shares through the conversion of fully convertible equity warrants. The company has conducted two separate warrant conversion exercises, significantly expanding its equity base and paid-up capital.

Initial Warrant Conversion - April 11, 2026

The first warrant conversion was approved by the board of directors during their meeting on April 11, 2026, involving 78,15,000 equity shares. These warrants were originally allotted on February 06, 2026, at an issue price of INR 13.50 per warrant on a preferential basis to non-promoter category investors.

Second Warrant Conversion - April 13, 2026

The board conducted another meeting on April 13, 2026, approving the conversion of an additional 39,00,000 fully convertible equity warrants. These warrants were also originally allotted to a non-promoter investor on February 06, 2026, at the same issue price of INR 13.50 per warrant.

Combined Allottee Distribution

The total equity shares from both conversions have been distributed among three non-promoter investors, demonstrating broad-based investor participation in the company's equity expansion.

Impact on Share Capital Structure

The combined warrant conversions have resulted in a substantial increase in the company's paid-up equity share capital, reflecting successful capital raising activities and providing enhanced financial resources for business operations.

Both warrant conversions were conducted in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring full regulatory compliance. The successful completion of these conversions demonstrates strong investor confidence in the company's prospects and provides substantial additional equity capital for future growth initiatives.

Mardia Samyoung Capillary Tubes Company Limited has filed its quarterly compliance certificate with BSE Limited for the quarter ended March 31, 2026, in accordance with SEBI (Depositories and Participants) Regulations, 2018. The submission, made on April 13, 2026, demonstrates the company's adherence to regulatory requirements for share dematerialization processes.

Regulatory Compliance Filing

The compliance certificate was submitted by Managing Director Dhaval Dharmendrabhai Joshi (DIN: 10778731) to BSE Limited's Corporate Relationship Department. The filing addresses the requirements under Regulation 74(5) of SEBI Depositories Regulations, ensuring proper documentation of dematerialization activities during the quarter.

Registrar Confirmation

Purva Sharegistry (India) Pvt. Ltd., the company's SEBI-registered share transfer agent (Registration: INR000001112), provided comprehensive confirmation of dematerialization activities. The registrar confirmed that all securities received from depository participants during the quarter were properly processed within prescribed timelines.

The confirmation certificate, issued by Compliance Officer Ms. Deepali Gaonkar, verified that:

• All dematerialization requests were confirmed or rejected appropriately
• Security certificates were mutilated and cancelled after verification
• Depository names were substituted in the register of members
• All processes adhered to regulatory timelines

Dematerialization Activity Summary

The detailed records reveal extensive dematerialization activity throughout the quarter, with transactions spanning from January 2, 2026, to March 30, 2026. The activity involved numerous individual and institutional shareholders across various folio numbers.

Major Shareholder Transactions

Ellyoung Metal Products P Ltd emerged as the most active participant in dematerialization during the quarter, with multiple large-volume transactions processed primarily in March 2026. The company's dematerialization activity included various certificate numbers with substantial share quantities.

Other notable participants included individual shareholders such as Parveen Ismail Mulla, Kokilaben Vithaldas Parekh, and Ramesh Lakhotia, among others, representing diverse retail investor participation in the dematerialization process.

Compliance Confirmation

The filing confirms Mardia Samyoung Capillary Tubes Company Limited's continued compliance with SEBI depositories regulations. The comprehensive documentation provided by both the company and its registrar demonstrates proper governance and adherence to regulatory frameworks governing share dematerialization processes in the Indian capital markets.